Home Molecular Dx Pharmacogenomic Testing

Pharmacogenomic Testing

Genetics Can Impact How Effective Psychedelic Drugs Are at Treating Neurological Conditions
Genetic Disorders

Genetics Can Impact How Effective Psychedelic Drugs Are at Treating Neurological Conditions

0
Pharmacogenetic Testing Could Improve Outcomes for Patients with Depression
Molecular Dx

Pharmacogenetic Testing Could Improve Outcomes for Patients with Depression

0
Avera Health, Sema4 Launch Joint Five-Year Precision Oncology Study
Artificial Intelligence

Avera Health, Sema4 Launch Joint Five-Year Precision Oncology Study

0
Michigan Blue Taps OneOme for Pharmacogenomics Pilot Program
Molecular Dx

Michigan Blue Taps OneOme for Pharmacogenomics Pilot Program

0
Castle Biosciences to Acquire Mental Health PGx Test Maker AltheaDx
Mental Health Disorders

Castle Biosciences to Acquire Mental Health PGx Test Maker AltheaDx

0
Leading PGx Resources Show Incongruous Gene-Drug Interactions, Dosing Recommendations
Molecular Dx

Leading PGx Resources Show Incongruous Gene-Drug Interactions, Dosing Recommendations

0
Mayo and Baylor Study Supports Preemptive Gene Testing
Molecular Dx

Mayo and Baylor Study Supports Preemptive Gene Testing

0
Tesis Bio to Provide PGx Testing for Frontier’s Senior Living Facilities
Molecular Dx

Tesis Bio to Provide PGx Testing for Frontier’s Senior Living Facilities

0
“Right Drug Dose Now” Act Should Help Implement Better Precision Medicine
Drug Discovery

“Right Drug Dose Now” Act Should Help Implement Better Precision Medicine

0
Maximizing Time Efficiencies with an End-to-End Automated Clinical Workflow for Pharmacogenomics Testing
Magazine Editions

Maximizing Time Efficiencies with an End-to-End Automated Clinical Workflow for Pharmacogenomics Testing

0
1234Page 1 of 4

Trending

X Chromosome-Linked Enzyme May Explain Women’s Higher Alzheimer’s Incidence

X Chromosome-Linked Enzyme May Explain Women’s Higher Alzheimer’s Incidence

Ginkgo Bioworks Acquires Circularis to Strengthen Advanced Therapeutic Capacity

Ginkgo Bioworks Acquires Circularis to Strengthen Advanced Therapeutic Capacity

Amyloid Plaques More Common in White People with Dementia

Amyloid Plaques More Common in White People with Dementia

Alexion, AstraZeneca Rare Disease Acquires LogicBio

Alexion, AstraZeneca Rare Disease Acquires LogicBio

Copyright © 2022 Genetic Engineering & Biotechnology News. All Rights Reserved.